Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ELV stock price vs WST: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WST's multiple
Needs WST P/E.
Implied fair value · at ELV's multiple
Needs ELV P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Elevance Health, Inc. · implied price per share
Bear
$158.07
Base
$203.66
Bull
$263.02
WEST PHARMACEUTICAL SERVICES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UnitedHealth Group Incorporated
ELV vs UNH
CVS Health Corporation
ELV vs CVS
HUMANA INC
ELV vs HUM
CENTENE CORP
ELV vs CNC
APTARGROUP, INC.
ELV vs ATR
BECTON DICKINSON & CO
ELV vs BDX
ICU MEDICAL INC/DE
ELV vs ICUI
TELEFLEX INC
ELV vs TFX
BAXTER INTERNATIONAL INC
ELV vs BAX
CARDINAL HEALTH INC
ELV vs CAH
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ELV can sustain its faster revenue growth while expanding margins toward WST's profitability profile, then the stock looks attractive on a relative valuation basis; otherwise, the large discount may simply reflect ELV's structurally lower margin quality versus WST.
ELV trades at a deep discount to WST on both earnings and sales multiples, which mathematically drives the large implied upside. However, the valuation gap is heavily influenced by business quality differences, with WST commanding a premium for much higher margins and ROIC.
Supporting Metrics
